Paclitaxel Injection, Solution
Product Images NDC 72205-062

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 72205-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-16-7ml-carton-label (100mg 16 7ml Carton Label)

Packaging label for Paclitaxel Injection, USP 6 mg/mL (100 mg/16.7 mL) intravenous solution by Novadoz Pharmaceuticals LLC. The label provides dilution instructions, storage conditions (20° to 25°C), and warnings including cytotoxic agent caution. Manufactured by MSN Laboratories, India, and distributed by Novadoz Pharmaceuticals in Piscataway, NJ. Contains one 16.7 mL multiple dose vial.*

FDA Label Image

100mg-16-7ml-vial-label (100mg 16 7ml Vial Label)

Label for Paclitaxel Injection, USP 6 mg/mL solution for intravenous use in a 16.7 mL multiple dose vial containing 100 mg total. Labeled as semisynthetic with warnings for cytotoxicity and dilution requirement prior to intravenous infusion. Manufactured by MSN Laboratories Pvt Ltd, India, and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. The label includes storage instructions, handling precautions, and a barcode.*

FDA Label Image

300mg-50ml-carton-label (300mg 50ml Carton Label)

Packaging label for Paclitaxel Injection, USP 300 mg/50 mL (6 mg/mL) intravenous solution by Novadoz Pharmaceuticals LLC. The label details semisynthetic formulation, dilution caution, cytotoxic agent warning, and storage instructions. Manufactured by MSN Laboratories India and distributed by Novadoz Pharmaceuticals in Piscataway, NJ.*

FDA Label Image

300mg-50ml-vial-label (300mg 50ml Vial Label)

Label for Paclitaxel Injection, USP 300 mg/50 mL (6 mg/mL) sterile solution for intravenous use by Novadoz Pharmaceuticals LLC. The label includes drug concentration, handling precautions, storage instructions, manufacturer (MSN Laboratories Private Limited, India), distributor contact details, and placeholder for lot and expiration information. Packaging indicates a 50 mL multiple dose vial.*

FDA Label Image

30mg-5ml-carton-label (30mg 5ml Carton Label)

Label for Paclitaxel Injection, USP solution at 30 mg/5 mL (6 mg/mL) in a multiple dose vial. The product is labeled as semisynthetic and cytotoxic, with warnings indicating dilution is required prior to intravenous infusion. It includes detailed dosage and storage instructions and identifies Novadoz Pharmaceuticals LLC as the distributor and MSN Laboratories Private Limited in India as the manufacturer.*

FDA Label Image

30mg-5ml-vial-label (30mg 5ml Vial Label)

Label for Paclitaxel Injection, USP 30 mg/5 mL (6 mg/mL) intravenous solution by Novadoz Pharmaceuticals LLC. It includes warnings about dilution prior to infusion and cytotoxicity. The label lists ingredients, storage instructions, manufacturer (MSN Laboratories, India), and distributor details. There is a barcode and a designated area for lot and expiration coding.*

FDA Label Image

Fig-1 (Figure 1)

A survival curve graph showing the proportion surviving over a 5-year period for two groups labeled Cc and Tc. The x-axis represents years from 0 to 5, and the y-axis shows the proportion surviving from 0 to 1. The graph includes a table with the number of subjects, events, and hazard ratio (HR) with 95% confidence intervals comparing the two groups. The number at risk for each group is shown below the x-axis at various time points.*

FDA Label Image

Fig-2 (Figure 2)

A survival curve chart comparing the proportion of subjects surviving over a five-year period between two groups labeled Cc and Tc. The y-axis represents the proportion surviving, and the x-axis represents years. The chart includes sample sizes, number of events, and a hazard ratio with confidence intervals.*

FDA Label Image

Fig-3 (Figure 3)

A line graph showing the proportion of disease-free individuals over a 4-year period comparing two groups labeled AC and AC+T. The graph includes a hazard ratio with confidence intervals and a table of the number of events and participants at risk over time for each group.*

FDA Label Image

Fig-4 (Figure 4)

A survival curve chart showing the proportion of patients surviving over a 4-year period for two groups labeled AC and AC+T. The chart includes a table with patient numbers, event counts, and a hazard ratio with confidence interval comparing the two groups. The x-axis represents years and the y-axis represents the proportion surviving.*

FDA Label Image

Fig-5 (Figure 5)

A survival curve chart depicting the proportion of patients disease-free over four years comparing two treatment groups: AC and AC+T. The graph includes a hazard ratio and confidence interval, with accompanying tables showing sample size, number of events, and number at risk over time for each group.*

FDA Label Image

Fig-6 (Figure 6)

A survival curve chart comparing the proportion of disease-free patients over a 4-year period between two treatment groups: AC and AC+T. The chart includes a table showing the number of events, hazard ratio, and confidence intervals for both groups, illustrating their disease-free survival rates over time.*

FDA Label Image

Fig-7 (Figure 7)

A survival curve chart comparing the proportion of disease-free patients over a 4-year period between two groups labeled AC and AC+T. The chart includes numbers at risk for each group at different time points, the number of events, hazard ratio (HR), and confidence interval (CI) in an inset table.*

FDA Label Image

Fig-8 (Figure 8)

A Kaplan-Meier survival curve graph depicting the proportion of patients disease-free over a period of 4 years. Two treatment groups, labeled AC and AC+T, are shown with the AC+T group maintaining a higher disease-free proportion. The graph includes a table with the number of patients, events, hazard ratio, and 95% confidence interval, as well as numbers at risk at specific time points for both groups.*

FDA Label Image

Structure (Structure)

Chemical structure of Paclitaxel, the active ingredient in a human prescription drug with intravenous injection form, strength 6 mg/mL, labeled by Novadoz Pharmaceuticals LLC. The structure shows the detailed molecular framework with multiple ring systems and functional groups typical of the Paclitaxel molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.